Fortress Biotech, Inc. (FBIO)
2.60
+0.13
(+5.26%)
USD |
NASDAQ |
Apr 02, 16:00
2.44
-0.16
(-6.15%)
After-Hours: 20:00
Fortress Biotech EPS Diluted (Quarterly) : -0.1976 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Journey Medical Corp. | -0.0459 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Oramed Pharmaceuticals, Inc. | 0.2274 |
| Avenue Therapeutics, Inc. | -0.2227 |
| Lyell Immunopharma, Inc. | -6.622 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.397M |
| Revenue (Quarterly) | 16.08M |
| Total Expenses (Quarterly) | 20.02M |
| Enterprise Value | 81.69M |
| Gross Profit Margin (Quarterly) | 58.97% |
| Profit Margin (Quarterly) | -33.57% |
| Earnings Yield | -4.60% |
| Normalized Earnings Yield | -17.19 |